Will Zymergen Stock Go Up?
Zymergen’s shares have received 1-year price objectives from four Wall Street analysts. Their ZY share price forecasts range from $2.60 to $4.00, and on average, they anticipate the company’s share price to reach $3.30 in the upcoming year, representing a potential upside of 35.8% from the stock’s current price.
What Is Zymergen Stock?
This page displays data from the NASDAQ ZY stock exchange, showing Zymergen Inc. stock price live at 2.43.
Is Zymergen A Good Investment?
Zymergen Inc’s real-time quote is 2.430 USD at 2023-01-13, but your current investment may be devalued in the future. If you are looking for stocks with good returns, Zymergen Inc stock may be a bad, high-risk 1-year investment option.
What Happen To Zymergen Stock?
Ginkgo Class A common stock will continue to trade on the NYSE under the ticker symbol DNA. Ginkgo is developing a platform that will make it easy for customers to program cells in the same way that we can program computers. Zymergen shares will no longer be traded on Nasdaq.
Why Is Zymergen Stock Dropping?
ZY has been decimated by the market as a result of no revenue in 2021/22 and the sudden departure of its CEO. The company designs advanced materials technologies to improve manufacturing processes.
Will Arc Stock Go Up?
At 2023-01-31, the quote for ARC Document Solutions Inc. is 3.350 USD. According to our forecasts, there will be a long-term increase. The “ARC” stock price prediction for 2028-01-26 is 6.222 USD. With a 5-year investment, the revenue is expected to be around 85.73 percent. Your current $100 investment could reach $185.73 in 2028.
Morgan Stanley, Sb Investment Advisers (UK) Ltd., ARK Investment Management LLC, ARK Genomic Revolution ETF, True Venture Partners IV, L.L.C., Baillie Gifford & Co., Data Collective II GP, LLC, Vanguard Group Inc., VTSMX – Vanguard Total Stock Market Index Fund Investor Shares, and…
Is Zymergen Publicly Traded?
In summary, Zymergen designs advanced materials technologies to improve manufacturing processes and went public in April 2021, raising approximately $500 million through an IPO.
Why Did Zymergen Stock Drop?
Last year, Zymergen’s stock plummeted after the company stated that it expected no product revenue in 2021 and “immaterial” product revenue in… Zymergen sought to use synthetic biology technology to develop eco-friendly products in areas ranging from paper packaging to pest control. However, the company largely failed to deliver on its vision, and the company’s stock plummeted as a result.
- How Will Ethereum 2.0 Improve Upon Existing Blockchain Platforms? - February 9, 2023
- Dogecoin Explained: What is Dogecoin and How Can You Use It? - February 9, 2023
- Smart Investing Strategies for Wise in 2018: A Share Price Forecast - February 5, 2023